Financials

  • Market Capitalization 321.31 M
  • Employee 161
  • Founded 2018
  • CEO N/A
  • Website www.lyell.com
  • Headquarter Delaware, United States
  • FIGI BBG00RNXFN14
  • Industry Biotecnologia
Receita total
Lucro líquido
Lucro básico por ação
Dívida total
Fluxo de caixa livre
Caixa e equivalentes de caixa
Índice preço/lucro
-1.47
Índice preço/fluxo de caixa
11.12 K

Related tickers

#NomePreços24h %7d %1M %1A %Capitalização de mercadoÚltimos 7 dias
3263
GALT
Galectin Therapeutics Inc. - Common Stock
4.88 USD-8.61%+8.69%+86.26%+74.29%321.38 M USD
3267
CTNM
Contineum Therapeutics, Inc. - Common stock
14.06 USD-3.50%-6.39%+10.97%-7.92%324.77 M USD
3316
ELDN
Eledon Pharmaceuticals, Inc. - Common Stock
3.98 USD-1.73%+2.05%+15.03%+3.11%307.21 M USD
3318
FHTX
Foghorn Therapeutics Inc. - Common Stock
5.18 USD-3.72%-19.81%+25.73%+26.96%304.14 M USD

Notícias